Laryngotracheal manifestations of gastroesophageal reflux disease

Current Opinion in Otolaryngology and Head and Neck Surgery

Volumn 4, Issue 2, 1996, Pages 138-142

  Blaugrund, James ^a   Kelly, James H ^a  

^a GREATER BALTIMORE MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CIMETIDINE; CISAPRIDE; FAMOTIDINE; HISTAMINE H2 RECEPTOR ANTAGONIST; LANSOPRAZOLE; METOCLOPRAMIDE; OMEPRAZOLE; PROTON PUMP INHIBITOR; RANITIDINE;

CLINICAL EXAMINATION; GASTROESOPHAGEAL REFLUX; HUMAN; LARYNX DISORDER; PATHOGENESIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; TRACHEA DISEASE;

EID: 0029940922     PISSN: 10689508     EISSN: None     Source Type: Journal    
DOI: 10.1097/00020840-199604000-00013     Document Type: Review

References (38)

1. Cherry J, Margulies SI: Contact ulcer of the larynx. Laryngoscope 1968, 78:1937-1940.
2. Delahunty JE, Cherry J: Experimentally produced vocal cord granulomas. Laryngoscope 1968, 78:1941-1947.
3. Toohill RJ, Mushtag E, Lehman RH: Otolaryngologic manifestations of gastroesophageal reflux disease. In Proceedings of the 24th World Congress of Otorhinolaryngology Head and Neck Surgery. Edited by Sacristan T, Alvarez-Vincent JJ, Bartual J, Antoli-Candela F, Rubio L. Amsterdam, the Netherlands: Kugler and Ghedini; 1990:3005-3009.
4. Jindal JR, Milbrath MM, Shaker R, Hogan WJ, Toohill RJ: Gastroesophageal reflux disease as a likely cause of "idiopathic" subglottic stenosis. Ann Otol Rhinol Laryngol 1994, 103:186-191. In this anecdotal study, seven patients with idiopathic subglottic stenosis are presented, six of whom had failed surgical intervention. Monitoring of pH was performed in five of these patients using three probes (pharyngeal, proximal, and distal). The study was positive for distal esophageal reflux in all of these patients but showed proximal reflux in only three and no documented episodes of pharyngeal reflux. All patients improved when antireflux measures were added to their therapeutic regimens.
5. Morrison MO: Is chronic gastroesophageal reflux a causative factor in glottic carcinoma? Otolaryngol Head Neck Surg 1988, 99:370-373.
6. Ward PH, Hanson DG: Reflux as an etiologic factor of carcinoma of the larynx. Laryngoscope 1988, 98:1195-1199.
7. Koufman JA: The otolaryngologic manifestations of gastroesophageal reflux disease. Laryngoscope 1991, 101(suppl 53):1-78.
8. Weusten BLAM, Akkermans LMA, van Berge-Henegouwen GP, Smout AJPM: Spatiotemporal characteristics of physiological gastroesophageal reflux. Am J Physiol 1994, 266:G357-G362.
9. Kadakia SC, Kikendall JW, Maydonovitch C, Johnson LF: Effect of cigarette smoking on gastroesophageal reflux measured by 24-h ambulatory esophageal pH monitoring. Am J Gastroenterol 1995, 90:1785-1790. Using prolonged pH monitoring and controling for the pharmacologic half-life of nicotine, this study shows that cigarette smoking significantly increased the percentage of time that the pH was lower than 4 during the 24-hour study period. This increase occurred predominantly during the day while the patient was in the upright posture and was associated with a 114% rise in subjective complaints of heartburn.
10. Koufman JA: Gastroesophageal reflux and voice disorders. In Diagnosis and Treatment of Voice Disorders. Edited by Rubin JS, Sataloff RT, Korovin GS, Gould WJ. New York: Igaku-Shoin; 1995:161-175. An excellent overview of reflux-related voice disorders and their treatment.
11. Wiener GJ, Koufman JA, Wu WC, Cooper JB, Richter JE, Castell DO: Chronic hoarseness secondary to gastroesophageal reflux disease: documentation with 24-h ambulatory pH monitoring. Am J Gastroenterol 1989, 84:1503-1508.
12. Katz PO: Ambulatory esophageal and hypopharyngeal pH monitoring in patients with hoarseness. Am J Gastroenterol 1990, 85:38-40.
13. Jacob P, Kahrilas PJ, Herzon G: Proximal esophageal pH-metry in patients with "reflux laryngitis." Gastroenterology 1991, 100:305-310.
14. McNally PR, Maydonovitch CL, Prosek RA, Collette RP, Wong PK: Evaluation of gastroesophageal reflux as a cause of idiopathic hoarseness. Dig Dis Sci 1989, 34:1900-1904.
15. Vaezi MF, Singh S, Richter JE: Role of acid and duodenogastric reflux in esophageal mucosal injury: a review of animal and human studies. Gastroenterology 1995, 108:1897-1907.
16. Caldwell MTP, Lawlor P, Byrne PJ, Walsh TN, Hennessy TPJ: Ambulatory oesophageal bile reflux monitoring in Barrett's oesophagus. Br J Surg 1995, 82:657-660.
17. Kauer WKH, Peters JH, DeMeester TR, Ireland AP, Bremner CG, Hagen JA: Mixed reflux of gastric and duodenal juices is more harmful to the esophagus than gastric juice alone. Ann Surg 1995, 222:525-533. This provocative study uses both prolonged pH and bilirubin monitoring to demonstrate significantly higher esophageal bilirubin exposure in patients with Barrett's esophagus as compared with those with erosive esophagitis and no injury. The authors also show that the majority of esophageal bilirubin exposure occurred when the pH was between 4 and 7. These findings may ultimately explain why a small but significant proportion of cases fail to resolve on acid-suppression therapy alone.
18. Wetscher GJ, Perdikis G, Kretchmar DH, Stinson RG, Bagchi D, Redmond EJ, Adrian TE, Hinder RA: Esophagitis in Sprague-Dawley rats is mediated by free radicals. Dig Dis Sci 1995, 40:1297-1305. Using a rat model, mixed reflux was shown to cause greater esophageal mucosal damage than acid reflux alone. The source of superoxide ions appears to be lipid peroxidation. Superoxide dismutase given prior to experimentally induced reflux prevented esophagitis. The role of glutathione in this process is proposed but less firmly established.
19. Wetscher GJ, Hinder PR, Bagchi D, Perdikis G, Redmond EJ, Glaser K, Adrian TE, Hinder RA: Free radical scavengers prevent reflux esophagitis in rats. Dig Dis Sci 1995, 40:1292-1296.
20. Fuchs KH, DeMeester TR, Albertucci M: Specificity and sensitivity of objective diagnosis of gastroesophageal reflux disease. Surgery 1987, 102:575-580.
21. Schindlbeck NE, Heinrich C, Konig A, Dendorfer A, Pace F, Muller-Lissner SA: Optimal thresholds, sensitivity, and specificity of long-term pH-metry for the detection of gastroesophageal reflux disease. Gastroenterology 1987, 93:85-90.
22. Bianchi Porro G, Pace F: Comparison of three methods of intraesophageal pH recordings in the diagnosis of gastroesophageal reflux. Scand J Gastroenterol 1988, 23:743-750.
23. Pujol A, Grande L, Ros E, Pera C: Utility of in patient 24 hour intraesophageal pH monitoring in diagnosis of gastroesophageal reflux. Dig Dis Sci 1988, 33:1134-1140.
24. Mattioli S, Pilotti U, Spangaro M, Grigioni WF, Zannoli R, Felice U, Conci A, Gozzetti G: Reliability of 24-hour home esophageal pH-monitoring in diagnosis of gastroesophageal reflux. Dig Dis Sci 1986, 34:71-78.
25. Ghillebert G, Demeyere AM, Janssens J, VanTrappen G: How well can quantitative 24-hour intraesophageal pH monitoring distinguish various degrees of reflux disease? Dig Dis Sci 1995, 40:1317-1324. This study challenges the accepted values for sensitivity and specificity of prolonged pH monitoring. Although the authors demonstrate that this modality remains an excellent tool for characterizing patterns of reflux in patients with severe esophagitis, they also show that it becomes less effective in patients with mild to moderate esophageal reflux.
26. Waring JP, Lacayo L, Hunter J, Katz E, Suwak B: Chronic cough and hoarseness in patients with severe gastroesophagsal reflux disease. Dig Dis Sci 1995, 40:1093-1097.
27. Cucchiara S, Santamaria F, Minella R, Alfieri E, Scoppa A, Calabrese F, Franco MT, Rea B, Salvia G: Simultaneous prolonged recordings of proximal and distal intraesophageal pH in children with gastroesophageal reflux disease and respiratory symptoms. Am J Gastroenterol 1995, 90:1791-1976.
28. Contencin P, Narcy P: Gastropharyngeal reflux in infants and children. Arch Otolaryngol Head Neck Surg 1992, 118:1028-1030.
29. Hanson DG, Kamel PL, Kahrilas PJ: Outcomes of antireflux therapy for the treatment of chronic laryngitis. Ann Otol Rhinol Laryngol 1995, 104:550-555. This study examines the clinical response of 182 patients to various levels of antireflux therapy and serves to illustrate the point that pH monitoring may not be necessary in the initial evaluation of patients with reflux laryngitis. However, the failure of the authors to document reflux using accepted methods prior to instituting therapy leaves the results suspect from a scientific point of view.
30. Fellenius E, Elander B, Wallmark B, Helander HF, Berglindh T: Inhibition of acid secretion in Isolated gastric glands by substituted benzimidazoles. Am J Physiol 1982, 243:G505-G510.
31. Pope CE: Acid-reflux disorders. N Engl J Med 1994, 331:656-660.
32. Tytgat GNJ: Long-term therapy for reflux esophagitis. N Engl J Med 1995, 333:1148-1150.
33. 2 receptor antagonists showed that omeprazole therapy was effective for at least 5 years. Patients were noted to have increased serum gastrin levels and an increase of micronodular argyrophil cell hyperplasia and atrophic gastritis.
34. Vigneri S, Termini R, Leandro G, Badalamenti S, Pontalena M, Savarino V, DiMario F, Battaglia G, Mela GS, Pilotto A, et al.: A comparison of five maintenance therapies for reflux esophagitis. N Engl J Med 1995, 333:1106-1110. Confirming the long-term efficacy of omeprazole in the treatment of reflux esophagitis, this study also clearly demonstrates its superiority over other medical therapies.
35. Blot WJ, Devesa SS, Kneller RW, Fraumeni JF Jr: Rising Incidence of adenocarcinoma of the esophagus and gastric cardia. JAMA 1991, 265:1287-1289.
36. Chow WH, Finkle WD, McLaughlin JK, Frankl H, Ziel HK, Fraumeni JF: The relation of gastroesophageal reflux disease and its treatment to adenocarcinoma of the esophagus and gastric cardia. JAMA 1995, 274:474-477.
37. Taylor TV: Gastro-oesophageal reflux disease. Br J Surg 1995, 82:579-581.
38. Deveney CW, Benner K, Cohen J: Gastroesophageal reflux and laryngeal disease. Arch Surg 1993, 128:1021-1025.